Literature DB >> 25435302

Matrix-specific anchors: a new concept for targeted delivery and retention of therapeutic cells.

Andrzej Steplewski1, Jolanta Fertala, Pedro Beredjiklian, Mark L Wang, Andrzej Fertala.   

Abstract

Biomedical strategies for tissue engineering and repair utilize specific cells, scaffolds, and growth factors to reconstruct elements of damaged tissue. The cellular element of these strategies is limited, however, by poor efficiency of delivery and retention of therapeutic cells in target sites. We propose that the presence of a cellular anchor that is able to specifically bind a defined element of target tissue will facilitate efficient binding and retention of therapeutic cells, thereby promoting repair of the target site. To do so, we engineered an artificial collagen-specific anchor (ACSA) that is able to specifically bind collagen I. The ACSA was engineered by creating a construct comprising rationally designed consecutive domains. The binding specificity of the ACSA was achieved by employing variable regions of a monoclonal antibody that recognizes a unique epitope present in human collagen I. Meanwhile, cell membrane localization of the ACSA was provided by the presence of a transmembrane domain. We determined that the ACSA was localized within cell membranes and interacted with its intended target, that is, collagen I. We have demonstrated that, in comparison to the control, the cells expressing the ACSA attached better to collagen I and exhibited improved retention in sites of seeding. We have also demonstrated that the presence of the ACSA did not interfere with cell proliferation, the biosynthesis of endogenous collagen I, or the biological functions of native collagen receptors. Since the presented cell delivery system utilizes a common characteristic of major connective tissues, namely the presence of collagen I, the findings described here could have a broad positive impact for improving the repair processes of tendon, ligament, bone, intervertebral disc, skin, and other collagen I-rich connective tissues. If successful, the ACSA approach to deliver cells will serve as an outline for developing cell delivery methods that target other elements of extracellular matrices, including other collagen types, laminins, and fibronectins.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25435302      PMCID: PMC4394883          DOI: 10.1089/ten.tea.2014.0401

Source DB:  PubMed          Journal:  Tissue Eng Part A        ISSN: 1937-3341            Impact factor:   3.845


  44 in total

1.  Integrin alpha(2)I domain recognizes type I and type IV collagens by different mechanisms.

Authors:  J Käpylä; J Ivaska; R Riikonen; P Nykvist; O Pentikäinen; M Johnson; J Heino
Journal:  J Biol Chem       Date:  2000-02-04       Impact factor: 5.157

2.  The D2 period of collagen II contains a specific binding site for the human discoidin domain receptor, DDR2.

Authors:  Birgit Leitinger; Andrzej Steplewski; Andrzej Fertala
Journal:  J Mol Biol       Date:  2004-12-03       Impact factor: 5.469

3.  Guilty by association: some collagen II mutants alter the formation of ECM as a result of atypical interaction with fibronectin.

Authors:  Hidetoshi Ito; Eileen Rucker; Andrzej Steplewski; Erin McAdams; Raymond J Brittingham; Tatiana Alabyeva; Andrzej Fertala
Journal:  J Mol Biol       Date:  2005-09-16       Impact factor: 5.469

Review 4.  Tendon: biology, biomechanics, repair, growth factors, and evolving treatment options.

Authors:  Roshan James; Girish Kesturu; Gary Balian; A Bobby Chhabra
Journal:  J Hand Surg Am       Date:  2008-01       Impact factor: 2.230

5.  Characterization of a chimeric T-cell receptor with specificity for the Hodgkin's lymphoma-associated CD30 antigen.

Authors:  A Hombach; C Heuser; R Sircar; T Tillmann; V Diehl; C Pohl; H Abken
Journal:  J Immunother       Date:  1999-11       Impact factor: 4.456

6.  Persistence of intracellular and extracellular changes after incompletely suppressing expression of the R789C (p.R989C) and R992C (p.R1192C) collagen II mutants.

Authors:  Deborah A Jensen; Andrzej Steplewski; Katarzyna Gawron; Andrzej Fertala
Journal:  Hum Mutat       Date:  2011-05-05       Impact factor: 4.878

Review 7.  The promise and potential pitfalls of chimeric antigen receptors.

Authors:  Michel Sadelain; Renier Brentjens; Isabelle Rivière
Journal:  Curr Opin Immunol       Date:  2009-03-25       Impact factor: 7.486

8.  Improving endothelial cell retention for single stage seeding of prosthetic grafts: use of polymer sequences of arginine-glycine-aspartate.

Authors:  A Tiwari; A Kidane; H Salacinski; G Punshon; G Hamilton; A M Seifalian
Journal:  Eur J Vasc Endovasc Surg       Date:  2003-04       Impact factor: 7.069

9.  Impaired dermal wound healing in discoidin domain receptor 2-deficient mice associated with defective extracellular matrix remodeling.

Authors:  Elvira Olaso; Hsin-Chieh Lin; Li-Hsien Wang; Scott L Friedman
Journal:  Fibrogenesis Tissue Repair       Date:  2011-02-02

10.  Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects.

Authors:  Luis A Ortiz; Frederica Gambelli; Christine McBride; Dina Gaupp; Melody Baddoo; Naftali Kaminski; Donald G Phinney
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-18       Impact factor: 12.779

View more
  1 in total

Review 1.  Secreted trophic factors of mesenchymal stem cells support neurovascular and musculoskeletal therapies.

Authors:  Heidi R Hofer; Rocky S Tuan
Journal:  Stem Cell Res Ther       Date:  2016-09-09       Impact factor: 6.832

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.